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Abstract
Background: The concept of developmental hemosta-
sis has been universally accepted. Physiological ref-
erence ranges for coagulation tests are available for
infants and children of different ages. However, on
Oriental children they are rare.
Methods: Results of preoperative activated partial
thromboplastin time (APTT) in neonates, infants,
children aged 1–18 years and adults with minor elec-
tive surgery in a university affiliated hospital were
reviewed retrospectively. Plasma activity of factors
VIII, IX, XI, XII (FVIII:C, FIX:C, FXI:C, FXII:C) and lupus
anticoagulants (LAC) in 47 children with prolonged
APTT and 34 adult controls were measured to inves-
tigate the causes of prolongation.
Results: Compared with adults, APTT values were
prolonged significantly and were age-dependent in
children, especially in neonates and infants aged
1–6 months. Mean values for FXII:C and FIX:C in chil-
dren with prolonged APTT values were significantly
lower than those in adults (p-0.001). Prolonged APTT
values correlated negatively with FXII:C and FIX:C,
and weakly with the LAC Screen ratio (LAC-SR) (r0.01s
–0.808, –0.705 and 0.372, ps0.000, 0.000 and 0.001,
respectively). There was weak negative correlation
between FXII:C and LAC-SR (r0.01s–0.277, ps0.012).
No significant correlation was seen between pro-
longed APTT values and FVIII:C or FXI:C.
Conclusions: APTT values change dynamically with
age during childhood and display a distinct pattern of
evolution in children. Lower values of FXII:C and
FIX:C, and presence of LAC contribute to the prolon-
gation of APTT values in Chinese children.
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Introduction
The concept of developmental hemostasis introduced
by Andrew et al. (1–3) in the late 1980s has been uni-
versally accepted (4). The hemostatic system of chil-
dren is significantly different from that in adults. Thus,
an understanding of developmental hemostasis and
the development of appropriate age-dependent ref-
erence ranges are pivotal for prevention, diagnosis,
and treatment of hemostatic problems during child-
hood (4–7). Physiological reference ranges are avail-
able for premature infants, full-term infants and
children from 1 to 16 years of age (1–9). However,
most reports are relevant to Caucasians (1–9), while
studies on developmental hemostasis in Oriental
children is rare.
Differences exist in the hemostatic system between
different racial/ethnic groups. For example, the inci-
dence and risk of venous thromboembolism (VTE) is
markedly lower in Asian/Pacific Islanders than in Cau-
casians and African Americans (10–14). VTE is not as
common in Chinese as in Caucasians (15). Genetic
risk factors related to VTE in Caucasians such as fac-
tor V Leiden and prothrombin G20210A mutations
are rare in Asian, especially in Chinese and Japanese
(16–22). The mean plasma concentrations of factors
VII, VIII and fibrinogen were lower in Japanese than
in Caucasians (23). In the MESA study, Chinese par-
ticipants had among the highest concentrations of
plasminogen activator inhibitor-1, but among the
lowest of all other hemostatic factors and endothelial
markers (24). The allele frequency of frequently occur-
ring C--)T polymorphism in the factor XII promoter
region at nucleotide (nt) 46 is higher in Orientals than
in Caucasians and Europeans (25, 26). This results in
lower plasma factor XII activity in Orientals (25, 27).
These differences stress the importance and necessity
for establishing reference ranges for clotting assays
related to race.
The activated partial thromboplastin time (APTT) is
the most widely used test for identifying abnormali-
ties in the intrinsic and common coagulation path-
ways, monitoring anticoagulant therapy with unfrac-
tionated heparin, and the detection of inhibitors of
coagulation, the most common of which is the lupus
anticoagulants (LAC) (28). Shortened APTT values
may be associated with hypercoagulability and
appear to be significantly associated with increased
risk of VTE (28). There have been several reports con-
cerning age-associated APTT values in healthy chil-
dren, in which inconsistent conclusions were drawn
with respect to values seen in adults (4, 6, 29–31). It
is recommended that coagulation laboratories devel-
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op age-related reference ranges specific to their own
testing systems for the local population (4, 7, 32). In
this study, we reviewed retrospectively age-associat-
ed evolvement of APTT values in healthy Chinese
subjects from birth through childhood. We also inves-
tigated prospectively the causes of longer APTT
values in healthy children compared with adults.
Materials and methods
Study population
Preoperative coagulation data from children aged 0–18 years
receiving minor elective surgery in Peking University Shenz-
hen Hospital, from May 2004 to October 2007 was collected
from the hospital information system and patient medical
record and reviewed. The hospital is located in Shenzhen,
where )80% of the population migrated from other parts of
China. Ethical approval was not required in this study, as
preoperative coagulation tests including APTT, prothrombin
time and platelet count were routinely performed in accor-
dance with document No. (2000) 412 enacted by the Ministry
of Health of the P.R. China. To qualify for the study, enrolled
subjects had to meet the following criteria: no family history
of bleeding or thrombophilia, no history of easy bruising, no
history of heart, lung, liver or kidney diseases, normal phys-
ical examination, a normal white blood cell count, and no
history of medication use for at least two weeks prior to
specimen collection. All enrolled healthy neonates and
infants from ages 1 to 6 months were full-term, did not expe-
rience any perinatal problems, and had no pathological jaun-
dice, infection or malnutrition. Specimens with inappropriate
ratio of blood to anticoagulant or hemolysis were excluded
from analysis. Individuals who were shown by other labo-
ratory examinations to have diseases affecting blood coag-
ulation were also excluded. Preoperative coagulation
examination data from adult control subjects were also
reviewed. Subjects in the control group were patients receiv-
ing minor elective surgery during the same period. They had
no history of hemorrhagic, thrombotic, cardiac, pulmonary,
hepatic or renal diseases, and no history of taking medica-
tions for at least two weeks prior to collection of specimens.
Laboratory analysis
Blood samples (2 mL) were obtained by venipuncture at the
same time that routine blood for preoperative analysis was
obtained. The blood was collected directly into a siliconized
glass vacutainer (Improve Medical Instrument’s Co, Ltd,
Guangzhou, China) containing 3.2% (109 mmol/L) buffered
sodium citrate with a 9:1 ratio of blood to citrate. The spec-
imens were centrifuged immediately at 2500 g for 15 min at
room temperature to prepare platelet-poor plasma (PPP) for
the preoperative coagulation screening tests. To investigate
the causes of increased APTT values in children compared
with adults, from March 2007 to October 2007, PPP from chil-
dren with APTT values longer than 43.0 s, the upper limit
of the adult reference interval, and PPP from adult control
subjects were collected immediately after the coagulation
screening tests were completed. Samples were frozen at
–808C until analysis of coagulation factors and LAC.
All coagulation assays were performed using the ACL
Futura coagulation analyzer (Instrumentation Laboratory,
Lexington, KY, USA) according to the manufacturer’s speci-
fications. For each assay, calibration was performed regu-
larly and control samples measured daily. Coagulation
screening tests were completed within 4 h following blood
collection. APTT was measured using Lyophilized silica
(HemosIL, Milan, Italy) reagent. This reagent is sensitive to
decreased concentrations of intrinsic factors and the pres-
ence of heparin anticoagulant. Results were measured in
seconds with a clot-based method. Activity of coagulation
factors VIII, IX, XI and XII (FVIII:C, FIX:C, FXI:C and FXII:C)
were determined using one-stage clotting methods with
respective factor-deficient plasma (HemosIL, Milan, Italy)
and the APTT reagent. LAC was assayed using LAC Screen/
LAC Confirm reagent (HemosIL, Milan, Italy), both of which
were improved Diluted Russell’s Viper Venom Test (DRVVT)
reagents. The LAC Screen reagent is poor in phospholipid,
making it sensitive to LAC. Specimens with a LAC Screen
ratio (LAC-SR) above 1.2 were confirmed with LAC Confirm
reagent, which is rich in phospholipid. Specimens with a
normalized LAC ratio above 1.2 were considered to be LAC
Confirm positive. The PPP was thawed and allowed to reach
room temperature before coagulation factors and LAC were
assayed in batch mode.
Statistical analysis
Statistical calculations were performed using SPSS version
17.0. Data are expressed as means with the 2.5th–97.5th per-
centile in parentheses, or means"1 SD (standard deviation).
Non-parametric data were analyzed using the Kruskal-Wallis
and Mann-Whitney U-tests. Comparison of the rate of two
samples was performed using Fisher’s exact probability test.
Parametric data were analyzed using Student’s t-test. Pear-
son correlation test was used for correlation.
Results
Study population
A total of 1466 infants and children met the enroll-
ment criteria. Cases that were excluded included 66
cases with inappropriate ratio of blood to anticoagu-
lant, 19 cases with specimen hemolysis, and three
cases with increased values of serum alanine amino-
transferase. One case of hereditary hypofibrinogen-
emia, one case of hereditary factor XI deficiency and
one case of von Willebrand factor deficiency con-
firmed by laboratory examination were also excluded.
Thus, 1375 infants and children were eligible for this
study. We also enrolled 697 adult subjects to serve as
a control group. The procedures that were performed
on the study subjects are summarized in Table 1.
Demographic features of the study cohort are shown
in Table 2.
Evolvement of APTT values with age
APTT values showed a distinctive pattern of change
in childhood (Table 2, Figure 1A). APTT values in neo-
nates were longest, followed by infants aged 1–6
months. APTT values in infants aged 6–12 months
were significantly shorter than those in infants aged
1–6 months (ps0.000), approaching adult values but
statistically different from adult values (ps0.017). The
hemostatic system changed gradually with increases
in age. No significant differences were found between
APTT values in children aged 1–2 years and adults
(p)0.05). However, APTT values showed a tendency
for prolongation, significant differences being found
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Table 1 Minor elective surgeries performed on the study
population.
Infants and Adult control
children, n subjects, n
Circumcision 201
Adenotonsillectomy 161
Surgical treatments or
plastic surgery for
Nasal septal deviation 19 201
Rhinopolypus 19 135
Scar 131 46
Pigmented naevus 53 14
Sebaceous cyst 34 31
Varicocele 51 139
Polydactyly 98
Cutaneous hemangioma 84
Cryptorchidism 80
Hydrocele 62
Cleft lip and palate 64
Inguinal hernia 45
Other minor elective 273 131
operations
Total 1375 697
Table 2 APTT values in healthy Chinese neonates, infants and children aged 1–18 years compared with adults.
Age n (males/females) APTT, s
Neonates and infants
1–30 daysi 18 (11/7) 48.09 (35.90–63.55)d
1–6 monthsi 31 (17/14) 45.53 (36.30–62.4)d
6–12 monthsi 18 (10/8) 39.43 (29.30–50.10)b,e,f
Children, years
1 66 (46/20) 37.90 (29.49–50.16)a,f
2 78 (55/23) 37.69 (28.78–46.41)a,f
3 75 (54/21) 38.39 (29.50–51.17)b,f
4 78 (58/20) 39.96 (29.79–49.37)d,g
5 101 (66/35) 39.10 (32.44–47.95)d,g
6 76 (56/20) 40.24 (32.01–50.40)d,g
7 78 (59/19) 39.98 (28.03–51.85)d,g
8 57 (45/12) 40.15 (31.56–52.82)d,g
9 66 (52/14) 38.50 (32.12–48.38)c,h
10 73 (48/25) 38.33 (29.11–47.31)b,h
11 64 (43/21) 39.32 (32.18–49.91)d,h
12 65 (41/24) 39.17 (30.11–52.18)c,h
13 67 (42/25) 39.20 (30.44–49.20)d,h
14 63 (46/17) 38.79 (28.78–47.23)c,h
15 61 (33/28) 38.94 (30.82–46.12)d,h
16 76 (37/39) 38.70 (27.10–46.86)d,h
17 64 (36/28) 38.29 (30.58–45.91)b,h
18 100 (46/54) 37.89 (29.02–47.37)b,h
Adultsi 697 (443/254) 36.91 (29.19–44.43)
APTT values are expressed as mean with 2.5th–97.5th percentile in parentheses. Compared with adults, APTT values are:
insignificantly different (ap)0.05); significantly prolonged (b0.01-p-0.05, c0.001-p-0.01, dps0.000). Compared with neo-
nates and infants aged 1–6 months, APTT values are significantly shortened (eps0.000). Intergroup comparison, APTT values
are insignificantly different (f,g,hp)0.05). iThe average ages of the four groups were 7.2"5.4 days, 4.4"1.3 months,
8.6"1.1 months and 31.06"8.09 years, respectively.
in children aged 3 years (ps0.034) and aged
4–8 years (ps0.000) when compared with adults.
Starting at 9 years of age, APTT values shortened
gradually, and approached adult levels by age 18.
However, these values were still different from those
seen in adults (ps0.038).
Comparison of APTT values in children at different
ages showed that no significant differences were
found in children aged 6 months to 3 years, 4–8 years
and 9–18 years, respectively. Thus, data in these age
groups were combined for statistical analysis. The
mean APTT value in the group of children 6 months
to 3 years of age, consisting of 237 infants and chil-
dren, was 38.10 (29.58–48.74) s; 4–8 years group, 390
children, 39.82 (31.20–49.32) s; and 9–18 years group,
699 children, 38.67 (30.40–46.78) s. APTT values in all
three combined groups were significantly longer than
those seen in the adult control group (p-0.001).
Changes in APTT values following combining of
groups is illustrated in Figure 1B.
Lower FXII and FIX, and presence of LAC
contributing to the prolongation of APTT
values in children
To explore the causes of prolongation of APTT values
in children, PPP from 47 children with prolonged
APTT value and PPP from 34 adult controls were col-
lected between March 2007 and October 2007 (Table
3). FVIII:C, FIX:C, FXI:C, FXII:C and LAC were meas-
ured in batches after thawing of PPP. The results
showed that FXII:C and FIX:C were significantly lower
in PPP from children compared with controls
(ps0.000). FVIII:C and FXI:C were not significantly dif-
ferent between the two groups (ps0.709 and 0.280,
respectively) (Table 3). Although the mean LAC-SR
seemed higher in PPP from children compared with
controls, the difference was not statistically significant
(ps0.073). Although five LAC Confirm positive cases
(10.6%) were found in PPP from children and none in
controls, no significant difference existed between
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Figure 1 Age-associated changes in APTT values in healthy Chinese children. Each bar represents the mean with 2.5th–97.5th
percentile.
(A) Distribution of APTT values in healthy Chinese neonates, infants and children aged 1–18 years. (B) Distribution of APTT
values in healthy Chinese neonates, infants and children after data of no significant differences in different age groups being
combined.
Table 3 Coagulation factor activities and LAC in children with prolonged APTT and adult control subjects.
Children Adults p-Value
n (males/females) 47 (33/14) 34 (23/11)
Age, years 4.54"4.46 34.21"6.29
APTT, s 45.27"2.12 35.66"2.61 0.000
FVIII:C, % 86.49"24.60 81.13"17.43 0.280
FIX:C, % 75.52"13.60 98.59"12.16 0.000
FXI:C, % 95.99"19.21 97.49"15.58 0.709
FXII:C, % 46.92"8.36 86.59"23.95 0.000
LAC-SR 1.03"0.10 1.00"0.07 0.073
LAC Confirm positive 5, 10.6 0, 0 0.071
cases and positive rate, %
Data are expressed as mean"1 SD.
the two groups (ps0.071). The prolonged APTT
values correlated negatively with FXII:C, FIX:C and
weakly with LAC-SR (r0.01s–0.808, –0.705 and 0.372,
ps0.000, 0.000 and 0.001, respectively) (Figure 2).
There was weak negative correlation between FXII:C
and LAC-SR (r0.01s–0.277, ps0.012, data not shown).
No significant correlation was found between pro-
longed APTT values and FVIII:C or FXI:C. The relation-
ship between APTT and coagulation factors and LAC
analyzed with stepwise multiple linear regression
could be expressed as follows:
APTT (s)s49.193–0.116 FXII:C (%)–0.116 FIX:C (%)
2q9.166 LAC-SR, r s0.771
The above results indicated that lower concentra-
tions of FXII:C and FIX:C, and the presence of LAC
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Figure 2 Correlation of APTT with FXII:C, FIX:C and LAC-SR.
The study population is described in Table 3.
(A) APTT values correlated negatively with FXII:C (d,——)
and FIX:C (s,– – -). (B) APTT values correlated weakly with
LAC-SR.
contributed to the prolongation of APTT values in
Chinese children.
Discussion
The hemostatic system evolves in a manner that
is age-dependent (5, 8). Plasma concentrations of
most pro- and anticoagulant proteins are decreased
throughout childhood. However, they provide effec-
tive hemostatic balance at a lower level compared
with adults (5, 6). This situation necessitates the gen-
eration of several appropriate age-dependent refer-
ence ranges to interpret laboratory data in pediatric
patients and prevent misclassification of children hav-
ing defects of factors and inhibitors of the coagulation
system (7). Since there are differences in the hemo-
static system among different racial/ethnic groups
(10–27), and also between different analyzer and re-
agent systems (4), coagulation laboratories should
develop age-related reference ranges specific to their
own testing systems for the local population (4, 7, 32).
In this study, we analyzed retrospectively the results
of preoperative APTT testing in childhood and adult
controls undergoing minor elective surgery. We eval-
uated age-dependent development and maturation of
the intrinsic coagulation system in healthy Chinese
children. Our results showed that APTT values
evolved with age and displayed a distinctive pattern
of development in childhood. This confirms the con-
cept of developmental hemostasis as elucidated by
Andrew et al. (1–3). Due to different analyzer and re-
agent systems used, comparison of numerical differ-
ences in APTT values in children in this study with
studies on other children (1–6, 8, 9, 29–31) is inappro-
priate. The adult APTT normal range in this study
(29.19–44.43 s) is longer than that in Caucasian adults
(24.6–36.0 s) (33) when the same analyzer and reagent
systems were used.
The prolonged APTT values in neonates could be
explained by markedly decreased plasma concentra-
tions of the vitamin K-dependent factors (1, 8, 34) and
contact factors, and partially by insufficient ratios of
plasma to citrate caused by higher hematocrits (35).
APTT values were also markedly prolonged in infants
aged 1–6 months, which could be due to the hemo-
static system of infants -6 months of age not being
fully mature (6, 7). However, as healthy full-term neo-
nates and infants aged 1–6 months who undergo
minor elective operations in our hospital are uncom-
mon, this study cannot elucidate in detail the changes
in APTT values on different days following birth,
which was one limitation of this study.
Near-adult values are achieved for most coagula-
tion components by 6 months of age (1, 3). APTT val-
ues in infants aged 6–12 months were significantly
shortened compared with infants aged 1–6 months
(ps0.000) and approximated adult values. No signif-
icant differences were found between APTT values
in children aged 1–2 years and adults (p)0.05). This
finding could be explained by development of the
hemostatic system with age. Interestingly, APTT val-
ues showed a tendency for prolongation with signifi-
cant differences seen in children 3 years of age
(ps0.034) and 4–8 years of age (ps0.000) compared
with adults. From 9 years of age, APTT values grad-
ually shortened, which could be ascribed to matura-
tion of the hemostatic system.
Prolongation of the APTT is commonly due to
decreased levels of contact factors (XI, XII, prekalik-
rein, high molecular weight kininogen), factors VIII
and IX, and the presence of LAC (28, 31, 36). During
the neonatal period, only low titers of factor XII
appear to contribute significantly to the abnormal
prolongation in APTT, while relative deficiencies of
prekalikrein and high molecular weight kininogen
usually do not have such effects (37). Our results sug-
gest that decreased concentrations of FXII:C and
FIX:C, and the presence of LAC contributed to the pro-
longation of APTT values in children. This differs
slightly from the conclusion of Gallistl et al. (31) about
causes for prolongation of the APTT in healthy Cau-
casian children. These authors suggest that APTT pro-
longation is caused by the combination of slightly
lower clotting factors (VIII, IX, XII and HMWK). How-
ever, several studies (1, 6, 8, 37) have shown that the
plasma factor VIII level in children was similar to that
of adults, and even reached adult values at birth.
Decreased levels of FXII:C and FIX:C in children in this
study are consistent with the results of Monagle et al.
(4), Andrew et al. (6) and Gallistl et al. (31). Low factor
XII is a common finding in otherwise normal individ-
uals (28, 36, 38). This finding accounted for nearly half
(7/16) of the prolonged APTT values seen in a healthy
Austrian population (38). Plasma factor XII activity
concentrations in Orientals are lower than those seen
in Caucasians due to higher allele frequency of fre-
quently occurring C--)T polymorphism in the factor
XII promoter region at nucleotide (nt) 46 (25–27). This
could partially explain the contribution of a markedly
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decreased FXII:C to prolongation of the APTT in
healthy Chinese children.
The prevalence of transient and asymptomatic anti-
phospholipid antibodies (aPL) and/or LAC are more
common in children than in adults (39–44), which can
be partly ascribed to acquired infections (39–48).
Since children suffer from infections more often than
adults, this might explain why children had a much
higher prevalence for LAC than adults (42), especially
in early childhood (43, 44). Male et al. (43) reported
that the prevalence of LAC in children peaked at 5
years of age. Similarly, Currimbhoy (44) found a sig-
nificantly higher prevalence of LAC positivity not
associated with symptoms in children younger than
12 years of age compared with older children (3.1%
vs. 0.5%). This may partially explain the age-associ-
ated phenomenon that APTT values displayed a ten-
dency for prolongation in children after the age of
3 years, and gradually shortened after 9 years.
A frequent association of transient aPL and/or LAC
with low factor XII exists (45, 48, 49). This suggests
that aPL and/or LAC play a role in the pathogenesis
of decreased factor XII in children. However, no
correlation between clotting tests indicative of LAC
and aPL (42), and no correlation of increased APTT
with abnormal thromboplastin inhibition or increased
aPL (31) were observed. During childhood, LAC may
be transient, and the longest persistent feature is a
prolongation of clotting tests, even when aPL and
phospholipid-dependent tests are no longer positive
(43, 47). LAC-SR correlated weakly with FXII:C and
APTT in this study, suggesting that decreased FXII:C
concentrations caused by LAC do not play a key role
in the mechanisms of APTT prolongation in children.
Our results show a distinct developmental pattern
of age-related APTT values and causes of APTT pro-
longation in otherwise healthy Chinese children.
These data will be helpful for accurate diagnosis and
management of neonates and children with suspect-
ed bleeding or clotting disorders. Although routine
coagulation testing to predict postoperative bleeding
risk in unselected patients prior to surgery or other
invasive procedures is not recommended (36, 50), our
results combined with bleeding scores from struc-
tured clinical histories (36, 50) should reduce investi-
gation of otherwise healthy Chinese children who are
found to have mildly increased APTT values com-
pared with adults, where routine coagulation tests are
performed according to regulations.
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